Drugs / Symbiotic
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 01 trial | ||||||
| Phase 0 | NCT01413659 | Sep 2011 → Dec 2012 | — | Mashhad University of Medical Sciences | Unknown | No outcome recorded |
| Phase 31 trial · 1 missed | ||||||
| Phase 3 | NCT01899677 | Jul → Sep 2013 | necrotizing enterocolitis | Zeynep Kamil Maternity and Pediatric Research and Training Hospital | Completed | Missed primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Symbiotic | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01413659 ↗ |
| Route | Oral | “Oral symbiotic every 8 h since 2 days before operation” NCT01413659 ↗ |